[1]袁 芳,叶妍贞,黄丽清.西替利嗪联合布地奈德吸入治疗对小儿哮喘急性发作期肺功能的影响[J].医学信息,2024,37(18):79-82.[doi:10.3969/j.issn.1006-1959.2024.18.014]
 YUAN Fang,YE Yan-zhen,HUANG Li-qing.Effect of Cetirizine Combined with Budesonide Inhalation on Pulmonary Function in Children with Acute Attack of Asthma[J].Journal of Medical Information,2024,37(18):79-82.[doi:10.3969/j.issn.1006-1959.2024.18.014]
点击复制

西替利嗪联合布地奈德吸入治疗对小儿哮喘急性发作期肺功能的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年18期
页码:
79-82
栏目:
论著
出版日期:
2024-09-15

文章信息/Info

Title:
Effect of Cetirizine Combined with Budesonide Inhalation on Pulmonary Function in Children with Acute Attack of Asthma
文章编号:
1006-1959(2024)18-0079-04
作者:
袁 芳叶妍贞黄丽清
信丰县人民医院儿科,江西 信丰 341600
Author(s):
YUAN FangYE Yan-zhenHUANG Li-qing
Department of Pediatrics,Xinfeng County People’s Hospital,Xinfeng 341600,Jiangxi,China
关键词:
小儿哮喘急性发作期西替利嗪布地奈德吸入肺功能
Keywords:
Acute attack of asthma in childrenCetirizineBudesonide inhalationLung function
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2024.18.014
摘要:
目的 探讨西替利嗪与布地奈德联用对小儿哮喘急性发作期肺功能的影响。方法 选择2020年3月-2022年3月在信丰县人民医院接受治疗的78例哮喘急性发作期患儿为研究对象,采用随机数字表法将其分成对照组和观察组,每组39例。对照组采用布地奈德吸入治疗,观察组采用布地奈德联合西替利嗪治疗。比较两组治疗前后肺功能[第1秒用力呼气容量(FEV1)、用力肺活量(FVC)和呼气高峰流量(PEFR)]、临床疗效、炎性指标[白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、C反应蛋白(CRP)]及不良反应发生率。结果 观察组FEV1、 FVC、 PEFR均优于对照组(P<0.05);观察组总有效率高于对照组(P<0.05);观察组IL-6、CRP水平低于对照组,IL-10水平高于对照组(P<0.05);观察组不良反应发生率低于对照组(P<0.05)。结论 西替利嗪与布地奈德联用治疗小儿哮喘急性发作期的疗效确切,可提高患儿的肺功能,同时具有良好的抗炎作用及安全性,值得临床应用。
Abstract:
Objective To investigate the effect of cetirizine combined with budesonide on pulmonary function in children with acute attack of asthma.Methods A total of 78 children with acute exacerbation of asthma who were treated in Xinfeng County People’s Hospital from March 2020 to March 2022 were selected as the research objects. They were divided into control group and observation group by random number table method, with 39 children in each group. The control group was treated with budesonide inhalation, and the observation group was treated with budesonide combined with cetirizine. Pulmonary function [forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PEFR)], clinical efficacy, inflammatory indexes [interleukin-6 (IL-6), interleukin-10 (IL-10), C-reactive protein (CRP)] and incidence of adverse reactions were compared between the two groups before and after treatment.Results FEV1, FVC and PEFR in the observation group were better than those in the control group (P<0.05). The total effective rate of the observation group was higher than that of the control group (P<0.05). The levels of IL-6 and CRP in the observation group were lower than those in the control group, and the level of IL-10 was higher than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05).Conclusion Cetirizine combined with budesonide is effective in the treatment of acute attack of asthma in children, which can improve the lung function of children, and has good anti-inflammatory effect and safety. It is worthy of clinical application.

参考文献/References:

[1]刘芳.西替利嗪滴剂与布地奈德吸入剂联用对哮喘急性发作患儿肺功能指标的影响[J].实用临床医药杂志,2020,24(3):87-89,93.[2]吴丙美,杨雪冰,寇永妹,等.西替利嗪滴剂联合布地奈德混悬液对小儿哮喘急性发作FENO和SOD的影响[J].中国医药导报,2019,16(14):144-147.[3]周炳文,王莎莎,颜世军.三药联合治疗对咳嗽变异性哮喘患儿免疫功能和气道炎症因子水平及肺功能的影响[J].中国医药,2022,17(2):200-204.[4]金晶晶,洪燕.西替利嗪对急性哮喘发作儿童治疗效果的影响[J].中国妇幼健康研究,2019,30(8):1003-1006.[5]刘娟,赵宏芳.西替利嗪辅助治疗对哮喘急性发作期患儿肺部通气功能及外周血巨噬细胞中Toll样受体水平的影响[J].实用临床医药杂志,2020,24(5):60-63,71.[6]丁妞,陈艳萍,吴碧琛,等.西替利嗪联合布地奈德对支气管哮喘患儿临床疗效以及血清骨膜蛋白和溶血卵磷脂水平的影响[J].中国医药,2021,16(10):1543-1547.[7]梁敏,边俊梅,李弯,等.布地奈德联合西替利嗪对哮喘轻中度发作患儿外周血TLR4及STAT1表达的影响[J].现代免疫学,2018,38(6):461-465.[8]刘峥,刘艺.布地奈德雾化吸入联合西替利嗪滴剂治疗儿童哮喘疗效及对呼出气一氧化氮影响[J].创伤与急危重病医学,2018,6(5):296-297,299.[9]李新华,闫一娇,林春艳,等.西替利嗪联合布地奈德对支气管哮喘患儿疗效及血清TGF-β1、MCP-1、SDF-1水平的影响[J].中国现代应用药学,2020,37(16):1998-2001.[10]郑蕾芳,程纯,朱静.布地奈德联合特布他林及异丙托溴铵雾化吸入治疗急性发作期中度儿童哮喘临床研究[J].中国药业,2021,30(2):52-55.[11]刘艳丽,刘晓佳,杨晓莹,等.探究布地奈德+沙丁胺醇联合肺部康复训练对儿童重度支气管哮喘急性发作的应用价值[J].临床和实验医学杂志,2022,21(14):1545-1548.[12]陈福将,吴超雄,何丽丹,等.吸入用复方异丙托溴铵溶液雾化吸入治疗儿童哮喘急性发作的临床研究[J].中国临床药理学杂志,2023,39(11):1523-1527.[13]熊学敏,王林中,邵荣昌,等.雾化吸入布地奈德对感染诱发哮喘急性发作期患儿γ干扰素、血清炎性因子水平和肺功能的影响[J].中国医学前沿杂志(电子版),2020,12(11):108-111.[14]东雪洁,贾广媛,张葆青,等.清咳平喘颗粒联合布地奈德和硫酸特布他林治疗小儿支气管哮喘急性发作期(热哮证)的疗效观察[J].现代药物与临床,2023,38(5):1142-1146.[15]胡玉菲,刘峰,柳俊芳.孟鲁司特联合布地奈德治疗支气管哮喘急性发作期患儿的效果及对免疫和肺功能的影响[J].解放军医药杂志,2020,32(6):51-55.[16]施娟,姜树中,潘剑蓉.孟鲁司特钠与布地奈德混悬液联合治疗对哮喘急性发作患儿肺功能和C-反应蛋白的影响[J].中华肺部疾病杂志(电子版),2019,12(3):358-360.[17]阳进,王瀚仪,肖玲,等.孟鲁司特钠联合布地奈德混悬液对哮喘急性发作患儿血清EOS、ECP水平和肺功能的影响[J].现代生物医学进展,2018,18(12):2392-2395.[18]韩光玺,单永胜,韩晓.加味麻杏石甘汤联合特布他林及布地奈德雾化吸入治疗小儿支气管哮喘急性发作临床研究[J].新中医,2020,52(13):32-35.[19]张磊,沙宁,张宇升.维生素D3辅助治疗小儿支气管哮喘急性发作及对外周血EOS、IRF1、ADAM8的影响[J].临床和实验医学杂志,2023,22(22):2427-2430.[20]代杰,赵敏.孟鲁司特联合雾化吸入布地奈德治疗小儿哮喘急性发作的疗效及对患儿血清炎性因子的影响[J].中国医院用药评价与分析,2019,19(1):63-65.

相似文献/References:

[1]周冬娟.布地奈德联合西替利嗪治疗小儿哮喘对患儿呼吸功能及免疫功能指标的影响[J].医学信息,2022,35(03):103.[doi:10.3969/j.issn.1006-1959.2022.03.024]
 ZHOU Dong-juan.Effects of Budesonide Combined with Cetirizine on Respiratory Function andImmune Function in Children with Asthma[J].Journal of Medical Information,2022,35(18):103.[doi:10.3969/j.issn.1006-1959.2022.03.024]
[2]张舒扬.双歧三联活菌联合西替利嗪治疗小儿湿疹及对其免疫球蛋白水平的影响[J].医学信息,2022,35(03):159.[doi:10.3969/j.issn.1006-1959.2022.03.042]
 ZHANG Shu-yang.Effect of Bifid Triple Viable Combined with Cetirizine on Immunoglobulin Levelsin Children with Atopic Dermatitis[J].Journal of Medical Information,2022,35(18):159.[doi:10.3969/j.issn.1006-1959.2022.03.042]

更新日期/Last Update: 1900-01-01